Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Characteristics and treatment regimens across ERS SHARP severe asthma registries.

van Bragt JJMH, Adcock IM, Bel EHD, Braunstahl GJ, Ten Brinke A, Busby J, Canonica GW, Cao H, Chung KF, Csoma Z, Dahlen B, Davin E, Hansen S, Heffler E, Horvath I, Korn S, Kots M, Kuna P, Kwon N, Louis R, Plaza V, Porsbjerg C, Ramos-Barbon D, Richards LB, Skrgat S, Sont JK, Vijverberg SJH, Weersink EJ, Yasinska V, Wagers SS, Djukanovic R, Maitland-van der Zee AH; SHARP CRC.

Eur Respir J. 2019 Oct 10. pii: 1901163. doi: 10.1183/13993003.01163-2019. [Epub ahead of print]

PMID:
31601713
2.

Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol.

von Bülow A, Backer V, Bodtger U, Søes-Petersen NU, Vest S, Steffensen I, Porsbjerg C.

Respir Med. 2018 Dec;145:41-47. doi: 10.1016/j.rmed.2018.10.020. Epub 2018 Oct 22.

PMID:
30509715
3.

Validation of ATS clinical practice guideline cut-points for FeNO in asthma.

Jeppegaard M, Veidal S, Sverrild A, Backer V, Porsbjerg C.

Respir Med. 2018 Nov;144:22-29. doi: 10.1016/j.rmed.2018.09.014. Epub 2018 Sep 22.

PMID:
30366580
4.

F eNO-based asthma management results in faster improvement of airway hyperresponsiveness.

Bernholm KF, Homøe AS, Meteran H, Jensen CB, Porsbjerg C, Backer V.

ERJ Open Res. 2018 Oct 3;4(4). pii: 00147-2017. doi: 10.1183/23120541.00147-2017. eCollection 2018 Oct.

5.

Bronchoscopic mucosal cryobiopsies as a method for studying airway disease.

Hvidtfeldt M, Pulga A, Hostrup M, Sanden C, Mori M, Bornesund D, Larsen KR, Erjefält JS, Porsbjerg C.

Clin Exp Allergy. 2019 Jan;49(1):27-34. doi: 10.1111/cea.13281. Epub 2018 Oct 12.

PMID:
30244522
6.

Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study.

Bulathsinhala L, Eleangovan N, Heaney LG, Menzies-Gow A, Gibson PG, Peters M, Hew M, van Boven JFM, Lehtimäki L, van Ganse E, Belhassen M, Harvey ES, Perez de Llano L, Maitland-van der Zee AH, Papadopoulos NG, FitzGerald JM, Porsbjerg C, Canonica GW, Backer V, Rhee CK, Verhamme KMC, Buhl R, Cosio BG, Carter V, Price C, Le T, Stagno d'Alcontres M, Gopalan G, Tran TN, Price D.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):578-588.e2. doi: 10.1016/j.jaip.2018.08.016. Epub 2018 Sep 1.

PMID:
30179741
7.

Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthma.

Poulsen NN, Bjerregaard A, Khoo SK, Laing IA, Le Souëf P, Backer V, Rapley L, Cohen SE, Barrett L, Thompson P, Baltic S, Porsbjerg C.

Respir Med. 2018 Jul;140:50-56. doi: 10.1016/j.rmed.2018.05.016. Epub 2018 May 19.

PMID:
29957280
8.

Feasibility of high-intensity training in asthma.

Toennesen LL, Soerensen ED, Hostrup M, Porsbjerg C, Bangsbo J, Backer V.

Eur Clin Respir J. 2018 May 11;5(1):1468714. doi: 10.1080/20018525.2018.1468714. eCollection 2018.

9.

Testing for Exercise-Induced Bronchoconstriction.

Brannan JD, Porsbjerg C.

Immunol Allergy Clin North Am. 2018 May;38(2):215-229. doi: 10.1016/j.iac.2018.01.010. Review.

PMID:
29631731
10.

Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults.

Porsbjerg C, Ulrik C, Skjold T, Backer V, Laerum B, Lehman S, Janson C, Sandstrøm T, Bjermer L, Dahlen B, Lundbäck B, Ludviksdottir D, Björnsdóttir U, Altraja A, Lehtimäki L, Kauppi P, Karjalainen J, Kankaanranta H.

Eur Clin Respir J. 2018 Mar 6;5(1):1440868. doi: 10.1080/20018525.2018.1440868. eCollection 2018. Review.

11.

Allergic asthma is associated with increased risk of infections requiring antibiotics.

Woehlk C, von Bülow A, Kriegbaum M, Backer V, Porsbjerg C.

Ann Allergy Asthma Immunol. 2018 Feb;120(2):169-176.e1. doi: 10.1016/j.anai.2017.11.015.

PMID:
29413341
12.

Advancing the management of obstructive airways diseases through translational research.

Porsbjerg C, Sverrild A, Baines KJ, Searles A, Maltby S, Foster PS, Brightling C, Gibson PG.

Clin Exp Allergy. 2018 May;48(5):493-501. doi: 10.1111/cea.13112. Epub 2018 Mar 13. Review.

PMID:
29412485
13.

Objective confirmation of asthma diagnosis improves medication adherence.

Backer V, Stensen L, Sverrild A, Wedge E, Porsbjerg C.

J Asthma. 2018 Nov;55(11):1262-1268. doi: 10.1080/02770903.2017.1410830. Epub 2017 Dec 26.

PMID:
29278942
14.

Exhaled and nasal nitric oxide in chronic rhinosinusitis patients with nasal polyps in primary care.

Frendø M, Håkansson K, Schwer S, Ravn AT, Meteran H, Porsbjerg C, Backer V, von Buchwald C.

Rhinology. 2018 Mar 1;56(1):59-64. doi: 10.4193/Rhin17.111.

PMID:
29166423
15.

Effects of Exercise and Diet in Nonobese Asthma Patients-A Randomized Controlled Trial.

Toennesen LL, Meteran H, Hostrup M, Wium Geiker NR, Jensen CB, Porsbjerg C, Astrup A, Bangsbo J, Parker D, Backer V.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):803-811. doi: 10.1016/j.jaip.2017.09.028. Epub 2017 Nov 10.

PMID:
29133220
16.

Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation.

Silkoff PE, Singh D, FitzGerald JM, Eich A, Ludwig-Sengpiel A, Chupp GC, Backer V, Porsbjerg C, Girodet PO, Dransfield MT, Baribaud F, Susulic VS, Loza MJ.

Biomark Insights. 2017 Sep 7;12:1177271917730306. doi: 10.1177/1177271917730306. eCollection 2017.

17.

Overweight in childhood and adolescence: Does it lead to airway hyperresponsiveness in adulthood?

Toennesen LL, Bjerregaard A, Porsbjerg C, Ulrik CS, Harmsen L, Backer V.

J Asthma. 2018 Feb;55(2):137-144. doi: 10.1080/02770903.2017.1318143. Epub 2017 Jul 31.

PMID:
28758814
18.

Environment Changes Genetic Effects on Respiratory Conditions and Allergic Phenotypes.

Song Y, Schwager MJ, Backer V, Guo J, Porsbjerg C, Khoo SK, Laing IA, Moses EK, LeSouëf P, Zhang GB.

Sci Rep. 2017 Jul 24;7(1):6342. doi: 10.1038/s41598-017-06791-y.

19.

Natural history of skin prick test reactivity: A 20-year prospective study of a random population sample of children and adolescents.

Schou Nielsen J, Meteran H, Ulrik CS, Porsbjerg C, Backer V.

Ann Allergy Asthma Immunol. 2017 Aug;119(2):184-188.e1. doi: 10.1016/j.anai.2017.05.001. Epub 2017 Jun 7.

PMID:
28599992
20.

High fractional exhaled nitric oxide and sputum eosinophils are associated with an increased risk of future virus-induced exacerbations: A prospective cohort study.

Bjerregaard A, Laing IA, Backer V, Sverrild A, Khoo SK, Chidlow G, Sikazwe C, Smith DW, Le Souëf P, Porsbjerg C.

Clin Exp Allergy. 2017 Aug;47(8):1007-1013. doi: 10.1111/cea.12935. Epub 2017 May 9.

PMID:
28390083
21.

Co-morbidities in severe asthma: Clinical impact and management.

Porsbjerg C, Menzies-Gow A.

Respirology. 2017 May;22(4):651-661. doi: 10.1111/resp.13026. Epub 2017 Mar 22. Review.

22.

Novel monoclonal treatments in severe asthma.

Meteran H, Meteran H, Porsbjerg C, Backer V.

J Asthma. 2017 Dec;54(10):991-1011. doi: 10.1080/02770903.2017.1296157. Epub 2017 Mar 13. Review.

PMID:
28287273
23.

The level of diagnostic assessment in severe asthma: A nationwide real-life study.

von Bülow A, Backer V, Bodtger U, Søes-Petersen NU, Assing KD, Skjold T, Porsbjerg C.

Respir Med. 2017 Mar;124:21-29. doi: 10.1016/j.rmed.2017.01.010. Epub 2017 Jan 27.

24.

A rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma.

Smith D, Helgason H, Sulem P, Bjornsdottir US, Lim AC, Sveinbjornsson G, Hasegawa H, Brown M, Ketchem RR, Gavala M, Garrett L, Jonasdottir A, Jonasdottir A, Sigurdsson A, Magnusson OT, Eyjolfsson GI, Olafsson I, Onundarson PT, Sigurdardottir O, Gislason D, Gislason T, Ludviksson BR, Ludviksdottir D, Boezen HM, Heinzmann A, Krueger M, Porsbjerg C, Ahluwalia TS, Waage J, Backer V, Deichmann KA, Koppelman GH, Bønnelykke K, Bisgaard H, Masson G, Thorsteinsdottir U, Gudbjartsson DF, Johnston JA, Jonsdottir I, Stefansson K.

PLoS Genet. 2017 Mar 8;13(3):e1006659. doi: 10.1371/journal.pgen.1006659. eCollection 2017 Mar.

25.

The impact of dysfunctional breathing on the assessment of asthma control.

Veidal S, Jeppegaard M, Sverrild A, Backer V, Porsbjerg C.

Respir Med. 2017 Feb;123:42-47. doi: 10.1016/j.rmed.2016.12.008. Epub 2016 Dec 18.

26.

Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults.

Bjerregaard A, Laing IA, Poulsen N, Backer V, Sverrild A, Fally M, Khoo SK, Barrett L, Baltic S, Thompson PJ, Chidlow G, Sikazwe C, Smith DW, Bochkov YA, Le Souëf P, Porsbjerg C.

Respir Med. 2017 Feb;123:34-41. doi: 10.1016/j.rmed.2016.12.010. Epub 2016 Dec 18.

27.

Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients.

Silkoff PE, Laviolette M, Singh D, FitzGerald JM, Kelsen S, Backer V, Porsbjerg CM, Girodet PO, Berger P, Kline JN, Chupp G, Susulic VS, Barnathan ES, Baribaud F, Loza MJ; Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study investigators.

J Allergy Clin Immunol. 2017 Sep;140(3):710-719. doi: 10.1016/j.jaci.2016.11.038. Epub 2017 Jan 13.

PMID:
28089872
28.

[Dysfunctional breathing in patients with asthma].

Andreasson KH, Skou ST, Porsbjerg C, Veidal S, Bødtger U.

Ugeskr Laeger. 2017 Jan 9;179(2). pii: V07160463. Review. Danish.

PMID:
28074763
29.

Eosinophilic airway inflammation in asthmatic patients is associated with an altered airway microbiome.

Sverrild A, Kiilerich P, Brejnrod A, Pedersen R, Porsbjerg C, Bergqvist A, Erjefält JS, Kristiansen K, Backer V.

J Allergy Clin Immunol. 2017 Aug;140(2):407-417.e11. doi: 10.1016/j.jaci.2016.10.046. Epub 2016 Dec 29.

PMID:
28042058
30.

Stability of FeNO and airway hyperresponsiveness to mannitol in untreated asthmatics.

Udesen PB, Westergaard CG, Porsbjerg C, Backer V.

J Asthma. 2017 Jun;54(5):530-536. doi: 10.1080/02770903.2016.1238928. Epub 2016 Sep 26.

PMID:
27668981
31.

Clinical characteristics of eosinophilic asthma exacerbations.

Bjerregaard A, Laing IA, Backer V, Fally M, Khoo SK, Chidlow G, Sikazwe C, Smith DW, Le Souëf P, Porsbjerg C.

Respirology. 2017 Feb;22(2):295-300. doi: 10.1111/resp.12905. Epub 2016 Sep 21.

PMID:
27649851
32.

Think twice - Diagnostic delay in a patient with acute chest pain.

Bang CL, Porsbjerg CM.

Respir Med Case Rep. 2016 Aug 20;19:94-7. doi: 10.1016/j.rmcr.2016.08.004. eCollection 2016.

33.

Smoking Cessation and the Microbiome in Induced Sputum Samples from Cigarette Smoking Asthma Patients.

Munck C, Helby J, Westergaard CG, Porsbjerg C, Backer V, Hansen LH.

PLoS One. 2016 Jul 8;11(7):e0158622. doi: 10.1371/journal.pone.0158622. eCollection 2016.

34.

Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.

Corti C, Fally M, Fabricius-Bjerre A, Mortensen K, Jensen BN, Andreassen HF, Porsbjerg C, Knudsen JD, Jensen JU.

Int J Chron Obstruct Pulmon Dis. 2016 Jun 22;11:1381-9. doi: 10.2147/COPD.S104051. eCollection 2016.

35.

Bronchial provocation testing does not detect exercise-induced laryngeal obstruction.

Walsted ES, Hull JH, Sverrild A, Porsbjerg C, Backer V.

J Asthma. 2017 Jan 2;54(1):77-83. doi: 10.1080/02770903.2016.1195843. Epub 2016 Jun 10.

PMID:
27285291
36.

Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.

Silkoff PE, Laviolette M, Singh D, FitzGerald JM, Kelsen S, Backer V, Porsbjerg C, Girodet PO, Berger P, Kline JN, Khatri S, Chanez P, Susulic VS, Barnathan ES, Baribaud F, Loza MJ; ADEPT Investigators.

Respir Res. 2016 Apr 23;17:43. doi: 10.1186/s12931-016-0360-5.

37.

Two-week inhalation of budesonide increases muscle Na,K ATPase content but not endurance in response to terbutaline in men.

Hostrup M, Jessen S, Onslev J, Clausen T, Porsbjerg C.

Scand J Med Sci Sports. 2017 Jul;27(7):684-691. doi: 10.1111/sms.12677. Epub 2016 Apr 7.

PMID:
27060857
38.

Increased asthma and adipose tissue inflammatory gene expression with obesity and Inuit migration to a western country.

Backer V, Baines KJ, Powell H, Porsbjerg C, Gibson PG.

Respir Med. 2016 Feb;111:8-15. doi: 10.1016/j.rmed.2015.12.003. Epub 2015 Dec 19.

39.

IL-33 is related to innate immune activation and sensitization to HDM in mild steroid-free asthma.

Porsbjerg C, Baines K, Gibson P, Bergqvist A, Erjefält JS, Sverrild A, Backer V.

Clin Exp Allergy. 2016 Apr;46(4):564-74. doi: 10.1111/cea.12702.

PMID:
26748611
40.

YKL-40 and genetic status of CHI3L1 in a large group of asthmatics.

Hansen JW, Thomsen SF, Porsbjerg C, Rasmussen LM, Harmsen L, Johansen JS, Backer V.

Eur Clin Respir J. 2015 Sep 16;2:25117. doi: 10.3402/ecrj.v2.25117. eCollection 2015.

41.

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.

Silkoff PE, Strambu I, Laviolette M, Singh D, FitzGerald JM, Lam S, Kelsen S, Eich A, Ludwig-Sengpiel A, Hupp GC, Backer V, Porsbjerg C, Girodet PO, Berger P, Leigh R, Kline JN, Dransfield M, Calhoun W, Hussaini A, Khatri S, Chanez P, Susulic VS, Barnathan ES, Curran M, Das AM, Brodmerkel C, Baribaud F, Loza MJ.

Respir Res. 2015 Nov 17;16:142. doi: 10.1186/s12931-015-0299-y.

42.

Diagnostic work-up in patients with possible asthma referred to a university hospital.

Backer V, Sverrild A, Ulrik CS, Bødtger U, Seersholm N, Porsbjerg C.

Eur Clin Respir J. 2015 Jul 7;2. doi: 10.3402/ecrj.v2.27768. eCollection 2015.

43.

The effect of Varenicline on smoking cessation in a group of young asthma patients.

Westergaard CG, Porsbjerg C, Backer V.

Respir Med. 2015 Nov;109(11):1416-22. doi: 10.1016/j.rmed.2015.07.017. Epub 2015 Jul 30.

44.

Airway responsiveness to mannitol in asthma is associated with chymase-positive mast cells and eosinophilic airway inflammation.

Sverrild A, Bergqvist A, Baines KJ, Porsbjerg C, Andersson CK, Thomsen SF, Hoffmann HJ, Gibson P, Erjefält JS, Backer V.

Clin Exp Allergy. 2016 Feb;46(2):288-97. doi: 10.1111/cea.12609.

PMID:
26252943
45.

Emerging corticosteroid agonists for the treatment of asthma.

Westergaard CG, Porsbjerg C, Backer V.

Expert Opin Emerg Drugs. 2015;20(4):653-62. doi: 10.1517/14728214.2015.1061503. Epub 2015 Jun 24. Review.

PMID:
26108455
46.

Investigating the effects of arctic dietary intake on lung health.

Baines KJ, Backer V, Gibson PG, Powell H, Porsbjerg CM.

Eur J Clin Nutr. 2015 Nov;69(11):1262-6. doi: 10.1038/ejcn.2015.85. Epub 2015 May 27.

PMID:
26014265
47.

Lung function impairment increases with age of diagnosis in adult onset asthma.

Porsbjerg C, Lange P, Ulrik CS.

Respir Med. 2015 Jul;109(7):821-7. doi: 10.1016/j.rmed.2015.04.012. Epub 2015 Apr 29.

48.

Combining the Mannitol Test and FeNO in the Assessment of Poorly Controlled Asthma.

Porsbjerg C, Sverrild A, Backer V.

J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):553-9. doi: 10.1016/j.jaip.2015.02.005. Epub 2015 Mar 29.

PMID:
25824441
49.

Impaired lung function is associated with systemic inflammation and macrophage activation.

Baines KJ, Backer V, Gibson PG, Powel H, Porsbjerg CM.

Eur Respir J. 2015 Feb;45(2):557-9. doi: 10.1183/09031936.00187514. Epub 2014 Dec 10. No abstract available.

50.

The prevalence of severe asthma and low asthma control among Danish adults.

von Bülow A, Kriegbaum M, Backer V, Porsbjerg C.

J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):759-67. doi: 10.1016/j.jaip.2014.05.005. Epub 2014 Jul 25.

PMID:
25439368

Supplemental Content

Loading ...
Support Center